Philips Healthcare has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its IQon Spectral computed tomography (CT) technology for spectral imaging. It adds a new dimension to CT imaging, delivering anatomical information and offering the ability to characterize structures based on their material content within a single scan. The enhanced image quality may help improve confidence in diagnoses and deliver operational efficiency.
AZE Technology announced the U.S. Food and Drug Administration (FDA) approval of Phoenix (Volume Registration Viewer), a viewer developed with a new concept for efficient and accurate image interpretation.
The Society of Cardiovascular Computed Tomography (SCCT) has published an update of the "SCCT Guidelines for the Interpretation and Reporting of Coronary CT Angiography: A Report of the Society of Cardiovascular Computed Tomography Guidelines Committee" document.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
AZE Technology announced the U.S. Food and Drug Administration (FDA) approval of Phoenix (Volume Registration Viewer), a viewer developed with a completely new concept for efficient and accurate image interpretation.
Samsung Electronics America Inc. announced availability in the United States of the Samsung RS80A, a high-resolution ultrasound system. Incorporating Samsung’s latest technology, the RS80A offers sophisticated digital image processing and high resolution to support accurate diagnosis.
A National Institutes of Health-funded study comparing treatment with widely used blood pressure medications, atenolol or losartan, in patients with Marfan syndrome who had an enlarged aortic root, found no significant difference in the rate of aortic-root dilation between the two treatment groups over three years.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
A new study by researchers from Icahn School of Medicine at Mount Sinai found that training medical students to use a handheld ultrasound device can enhance the accuracy of their physical diagnosis.
CeloNova BioSciences, Inc., announced that positive first-in-man (FIM) clinical trial results found its Cobra PzF coronary stent system with an advanced nano-thin coating of Polyzene-F polymer to be a safe and effective routine interventional treatment for real-world and complex patients with heart disease.
Men who have asymptomatic subclinical vascular disease are more likely to develop erectile dysfunction than men who don’t have early-stage vascular disease, according to research presented at the American Heart Association’s (AHA) Scientific Sessions 2014.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Grayhill will display its new optically bonded Instinct touch panel, capable of recognizing up to 10 touch points simultaneously, at the 2014 Radiological Society of North America (RSNA) annual meeting.
Bracco Diagnostics Inc. announced the availability of its Isovue (iopamidol injection) Imaging Bulk Package (IBP), a specific combination multi-patient, multi-dose compliant contrast medium approved by the U.S. Food and Drug Administration (FDA) for point-of-care use in the computed tomography (CT) suite.

Long-term overtreatment with the anti-clotting drug warfarin combined with antiplatelet therapy to prevent stroke may raise the risk of dementia in people with atrial fibrillation.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Obesity is commonly measured as a person’s body mass index (BMI), but a Loyola University Medical Center study has found that the layer of fat around the outside of the heart is more closely associated with atrial fibrillation than BMI.
According to a statement in Health Data Management, Ochsner Health System in New Orleans, developed a program utilizing a Carematix Blipcare wireless weight scale for remote patient monitoring to cut readmissions of heart failure patients by 40 percent.
A 19-year-old woman was successfully implanted with the SynCardia temporary Total Artificial Heart and bridged to a donor heart transplant after cardiac surgeons used 3-D virtual implantation to determine she was fit-eligible for the procedure.